Paysign (NASDAQ:PAYS) reported what executives described as the strongest start to a year in the company’s history, with first-quarter 2026 revenue rising 50.8% year over year to $28 million and profitability expanding sharply as its patient affordability business became its largest revenue contributor.
President and CEO Mark Newcomer said on the company’s earnings call that net income increased 110% to $5.4 million, while adjusted EBITDA rose 113% to $10.6 million. He also highlighted a 1,040-basis-point improvement in operating margin, which he said demonstrated “the operating leverage inherent in our business as we scale across healthcare and financial ecosystems.”
